Kiduja India

Why is Kiduja India Ltd falling/rising?

As of 18-Jul, Kiduja India Ltd's stock price is declining, currently at 15.17, reflecting a significant underperformance compared to the Sensex, with a year-to-date drop of 37.52%. The stock is trading below all major moving averages and has seen a notable decrease in investor participation, indicating a bearish trend.

As of 18-Jul, Kiduja India Ltd's stock price is falling, currently at 15.17, which reflects a decrease of 0.79 or 4.95%. The stock has underperformed significantly compared to the benchmark Sensex, which has gained 0.75% over the past week, while Kiduja India Ltd has dropped by 5.07%. Over the past month, the stock has also declined by 4.35%, contrasting with the Sensex's increase of 1.29%. Year-to-date, the stock is down 37.52%, while the Sensex has only fallen by 8.30%. <BR><BR>The stock has been on a consecutive decline for the last two days, with a total return of -5.07% during this period. Additionally, Kiduja India Ltd is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a notable decrease in investor participation, with delivery volume dropping by 71.17% compared to the 5-day average. This lack of trading activity suggests reduced interest in the stock, contributing to its falling price. Overall, these factors indicate a persistent downward trend in Kiduja India Ltd's stock price.

Which are the latest news on Kiduja India?

How big is Kiduja India?

As of 10th June, Kiduja India Ltd has a market capitalization of 38.00 Cr, with recent net sales of 22.19 Cr and a net profit of 2.22 Cr. As of March 2025, the company reported shareholder's funds at a loss of 23.66 Cr and total assets valued at 52.96 Cr.

As of 10th June, Kiduja India Ltd has a market capitalization of 38.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Kiduja India reported Net Sales of 22.19 Cr and a Net Profit of 2.22 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds stood at a loss of 23.66 Cr and Total Assets were valued at 52.96 Cr.

Who are in the management team of Kiduja India?

The management team of Kiduja India consists of A D Jaipuria (Managing Director), Archana A Jaipuria, Samir Singhai (both Non-Executive & Independent Directors), Ujjval A. Jaipuria, Kushal A. Jaipuria (Directors), and Vivek Tekriwal (Independent Director).

The management team of Kiduja India includes the following individuals:<BR><BR>1. A D Jaipuria - Managing Director<BR>2. Archana A Jaipuria - Non-Executive & Independent Director<BR>3. Samir Singhai - Non-Executive & Independent Director<BR>4. Ujjval A. Jaipuria - Director<BR>5. Kushal A. Jaipuria - Director<BR>6. Vivek Tekriwal - Independent Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

Who are the peers of the Kiduja India?

Kiduja India's peers include Ajcon Global, Prism Medico, Anupam Finserv, and others, with varying management risks and growth rates. In terms of returns, Kiduja India has a 1-year return of -20.46%, better than Biogen Pharma's -64.95% but worse than Prism Medico's 87.28%.

Peers: The peers of Kiduja India are Ajcon Global, Prism Medico, Anupam Finserv, Madhusudan Sec., HB Stockholdings, Glance Finance, Nagreeka Cap., Biogen Pharma, Sugal & Damani.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ajcon Global, Anupam Finserv, Madhusudan Sec., HB Stockholdings, Glance Finance, and the rest. Below Average management risk is found at Prism Medico, Biogen Pharma, and the rest. Average management risk is noted at Nagreeka Cap. Growth is Excellent for Madhusudan Sec. and Sugal & Damani, Good for Nagreeka Cap., while Below Average growth is seen at Ajcon Global, Prism Medico, Anupam Finserv, HB Stockholdings, Biogen Pharma, and the rest. Kiduja India does not qualify in any category.<BR><BR>Return Snapshot: Prism Medico has the highest 1-year return at 87.28%, while Biogen Pharma has the lowest at -64.95%. Kiduja India's 1-year return of -20.46% is better than Biogen Pharma's but worse than Prism Medico's. Additionally, several peers, including HB Stockholdings, Glance Finance, Biogen Pharma, Sugal & Damani, and others, have negative six-month returns.

What does Kiduja India do?

Kiduja India Ltd is an investment company focused on equity markets within the NBFC sector, categorized as a Micro Cap. As of March 2026, it reported net sales and profit of 0 Cr, with a market cap of INR 38 Cr.

Overview:<BR>Kiduja India Ltd is an India-focused investments company specializing in equity markets, operating within the Non-Banking Financial Company (NBFC) sector and categorized as a Micro Cap.<BR><BR>History:<BR>Kiduja India Ltd was founded in November 1985. The company has undergone status changes, including converting 2,23,000 Fully Convertible Debentures into Equity Shares in 1996 and raising its Equity Share Capital again in 1997. The most recent quarterly results reported net sales and net profit of 0 Cr for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2026)<BR>- Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026)<BR>- Market-cap value: INR 38 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 2.00<BR>- Industry P/E: 20<BR>- Dividend Yield: 0.00%<BR>- Debt-Equity: -1.51<BR>- Return on Equity: -110.21%<BR>- Price to Book: -1.78<BR><BR>Contact Details:<BR>- Address: 127-B Mittal Tower, Nariman Point, Mumbai, Maharashtra: 400021<BR>- Phone: 91-022-2282 0280/4002 2100<BR>- Email: kiduja.compliance@yahoo.com<BR>- Website: https://kiduja.com

Are Kiduja India Ltd latest results good or bad?

Kiduja India Ltd's latest Q4 FY26 results are concerning, with a net profit decline of 88.03% and net sales dropping 99.01%. The company faces significant financial distress, indicated by a negative book value and current liabilities exceeding current assets.

Kiduja India Ltd's latest results for Q4 FY26 are concerning. The company reported a net profit of ₹0.14 crores, which is an 88.03% decline from the previous quarter. More alarmingly, net sales plummeted to just ₹0.03 crores, reflecting a staggering 99.01% drop compared to the previous quarter's sales of ₹3.04 crores. This erratic revenue pattern has been a persistent issue for the company, indicating significant operational challenges.<BR><BR>Additionally, the company has a negative book value of ₹-9.86 per share and a negative net worth of ₹-23.66 crores, which raises serious concerns about its financial health. Current liabilities exceed current assets by approximately ₹24 crores, further complicating its ability to meet short-term obligations.<BR><BR>Overall, these results suggest that Kiduja India Ltd is facing fundamental financial distress, making the outlook for the company quite negative.

Should I buy, sell or hold Kiduja India Ltd?

Is Kiduja India overvalued or undervalued?

As of December 4, 2025, Kiduja India is considered undervalued with a PE ratio of -7.32 and significant growth potential, especially when compared to peers like Bajaj Finance and Life Insurance, despite a year-to-date decline of -95.62%.

As of 4 December 2025, Kiduja India has moved from a risky to a very attractive valuation grade. The company is currently undervalued, evidenced by its PE ratio of -7.32, an EV to EBITDA ratio of -22.89, and a PEG ratio of 0.00. These figures suggest significant potential for recovery and growth, especially considering the negative valuations compared to its peers.<BR><BR>In comparison, Bajaj Finance is deemed very expensive with a PE ratio of 34.9, while Life Insurance is very attractive with a PE ratio of 10.85. Kiduja India's valuation metrics indicate it is trading at a substantial discount relative to these peers, reinforcing the notion of being undervalued. Despite recent stock performance showing a significant decline year-to-date of -95.62% compared to a 9.12% increase in the Sensex, the long-term potential remains promising given its current valuation metrics.

How has been the historical performance of Kiduja India?

Kiduja India's historical performance shows significant fluctuations, with net sales rising to 45.03 crore in March 2024 before plummeting to 6.31 crore in March 2025, alongside a shift from a profit of 33.94 crore to a loss of 6.26 crore in the same period. Despite these challenges, cash flow from operating activities improved to 72 crore in March 2025.

Answer:<BR>The historical performance of Kiduja India shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Kiduja India's net sales experienced a notable increase from 20.67 crore in March 2019 to 45.03 crore in March 2024, before dropping sharply to 6.31 crore in March 2025. The total operating income followed a similar trend, peaking at 45.03 crore in March 2024 and then declining to 6.31 crore in March 2025. The company's operating profit margin was positive at 75.37% in March 2024 but turned negative at -99.21% in March 2025, reflecting a significant deterioration in profitability. The profit before tax also mirrored this decline, moving from a profit of 33.94 crore in March 2024 to a loss of 6.25 crore in March 2025. The profit after tax showed a similar pattern, transitioning from a profit of 33.94 crore in March 2024 to a loss of 6.26 crore in March 2025. The company's total liabilities decreased from 121.14 crore in March 2024 to 52.96 crore in March 2025, while total assets also fell from 121.14 crore to 52.96 crore in the same period. Cash flow from operating activities was positive at 72 crore in March 2025, contrasting with a negative cash flow of -56 crore in March 2024, indicating a recovery in cash generation despite the overall financial challenges.

How has been the historical performance of Kiduja India?

Kiduja India's historical performance has shown significant fluctuations, with net sales dropping from 45.03 Cr in March 2024 to 6.31 Cr in March 2025, resulting in a negative profit after tax of -6.26 Cr. Despite challenges, cash flow from operating activities improved to 72.00 Cr in March 2025, indicating some operational recovery.

Answer:<BR>The historical performance of Kiduja India shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Kiduja India's net sales have varied dramatically, with a notable increase to 6.31 Cr in March 2025 from 45.03 Cr in March 2024, following a period of no sales in the previous years. The total operating income reflects a similar trend, peaking at 45.03 Cr in March 2024 before dropping to 6.31 Cr in March 2025. The company has faced challenges with total expenditure, which rose to 12.57 Cr in March 2025 from 11.09 Cr in March 2024, leading to an operating profit of -6.26 Cr in March 2025, a decline from 33.94 Cr in the previous year. Interest expenses have also increased significantly to 11.20 Cr in March 2025 from 9.55 Cr in March 2024. Consequently, the profit before tax turned negative at -6.25 Cr in March 2025, down from 33.94 Cr in March 2024, resulting in a profit after tax of -6.26 Cr in March 2025. The company's equity capital has increased slightly to 2.40 Cr in March 2025, while reserves remain negative at -26.06 Cr. The total liabilities decreased to 52.96 Cr in March 2025 from 121.14 Cr in March 2024, with total assets also declining to 52.96 Cr. Cash flow from operating activities showed a positive trend at 72.00 Cr in March 2025, contrasting with a negative cash flow of -56.00 Cr in March 2024, indicating some operational recovery despite the overall financial challenges.

Who are the top shareholders of the Kiduja India?

The top shareholder of Kiduja India is Ashish Jaipuria, holding 55.0%. Individual investors own 22.49%, with the highest public shareholder being Amit Babulal Agarwal at 2.24%.

The top shareholders of Kiduja India are primarily the promoters, with Ashish Jaipuria holding the largest share at 55.0%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) involved. The highest public shareholder is Amit Babulal Agarwal, who holds 2.24%. Additionally, individual investors collectively own 22.49% of the company.

What is the technical trend for Kiduja India?

As of June 4, 2025, Kiduja India shows a mildly bearish trend, with mixed signals from MACD, Bollinger Bands, and moving averages indicating weak bearish sentiment but potential for slight recovery.

As of 4 June 2025, the technical trend for Kiduja India has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD indicating mild bullishness while the monthly MACD remains bearish. The Bollinger Bands and KST both show mildly bearish signals on a weekly and monthly basis. The daily moving averages are bearish, which adds to the overall negative sentiment. The Dow Theory reflects a mildly bearish trend on the weekly chart, with no trend on the monthly. Overall, the indicators suggest a weak bearish sentiment in the short term, with potential for slight recovery.

When is the next results date for Kiduja India?

No Upcoming Board Meetings

Has Kiduja India declared dividend?

No Dividend History Available